Compare TECX & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TECX | TRTX |
|---|---|---|
| Founded | 2019 | 2014 |
| Country | United States | United States |
| Employees | 60 | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 554.1M | 606.5M |
| IPO Year | N/A | N/A |
| Metric | TECX | TRTX |
|---|---|---|
| Price | $29.27 | $8.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $75.20 | $9.83 |
| AVG Volume (30 Days) | 189.7K | ★ 530.6K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 11.55% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.78 |
| Revenue Next Year | N/A | $4.14 |
| P/E Ratio | ★ N/A | $14.82 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.39 | $7.44 |
| 52 Week High | $35.99 | $9.85 |
| Indicator | TECX | TRTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 64.06 |
| Support Level | $28.31 | $8.40 |
| Resistance Level | $31.88 | $8.68 |
| Average True Range (ATR) | 1.53 | 0.17 |
| MACD | -0.17 | 0.03 |
| Stochastic Oscillator | 48.05 | 63.85 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.